首页> 外文期刊>Applied economics letters >The price effect of allowing non-pharmacy outlets to sell OTC drugs in Korea
【24h】

The price effect of allowing non-pharmacy outlets to sell OTC drugs in Korea

机译:允许非药店在韩国销售非处方药的价格效应

获取原文
获取原文并翻译 | 示例
           

摘要

By the amendment of the Pharmaceutical Affairs Act in 2012, non-pharmacy outlets (confined to 24-hour convenience stores) in Korea were permitted to sell 13 over-the-counter (OTC) drugs. This article empirically examines the effect of the regulatory reform on OTC drug prices. To do so, we use county-level price data of 7 OTC drugs for the years of 2012 and 2013. Among them, 2 OTC drugs are available at non-pharmacy outlets due to the deregulation, and the remaining 5 are still only available at pharmacies. Employing a difference-in-differences estimation strategy, we find that after the regulatory reform, prices of the 2 OTC drugs increased by only 1.1% while those of the rest 5 increased by 6.5%. This result has implications for the government's policy of designating non-pharmacy outlets that can sell OTC drugs from the viewpoint of consumer welfare.
机译:根据2012年《药品事务法》的修正案,韩国的非药店(仅限24小时便利店)被允许出售13种非处方药。本文从经验上考察了监管改革对非处方药价格的影响。为此,我们使用了2012年和2013年的县级7种非处方药价格数据。其中,由于放宽管制,非药房有2种非处方药可用,其余5种仍仅在药房。通过采用差异差异估算策略,我们发现,在监管改革之后,两种OTC药品的价格仅上涨了1.1%,而其余5种药品的价格上涨了6.5%。从消费者福利的角度来看,这一结果对政府指定可以出售非处方药的非药店的政策产生了影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号